Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions (Q56972032)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions	article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

based on heuristic

inferred from title

World Health Organization

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Domenico Motola

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

C Biagi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

V Conti

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

N Montanaro

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

M Melis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

E Buccellato

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

M Donati

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

A Covezzoli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

R Amato

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

L Pazzi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

A Vaccheri

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

0 references

publication date

20 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

70

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1505-1512

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is monthly retreatment with intravitreal bevacizumab (Avastin) necessary in neovascular age-related macular degeneration?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aflibercept in wet AMD: specific role and optimal use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MANTA 1-year results: the anti-VEGF debate continues

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region).

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25234795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-014-1755-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25234795%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56972032&oldid=2213209331"